Madison-based biotech Immuto Scientific Inc. announced that it has successfully closed on a $2.3 million seed-funding round. The funding will enable the company to scale up equipment and staffing to provide commercial analytical research services. Wisconsin Investment Partners led the round with other investors including Wisconsin Alumni Research Foundation (WARF), Great Oaks Venture Capital – New York, BrightStar Foundation, Golden Angels Investors, Tundra Angels, and Milwaukee Venture Partners. Immuto Scientific provides analytical research services for drug discovery using proprietary technologies that accelerate the drug discovery process.